Furthermore, our findings indicate that specific PD-L1 N-linked glycosylation sites are required for its ability to promote tumor growth and metastasis in vivo, and shed light on the clinical implications of these findings in breast cancer patients (using the TCGA dataset). Here, CD274 is linked to breast cancer.